Excess deaths from all causes and by COVID-19 in Brazil in 2020
Carregando...
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
REVISTA DE SAUDE PUBLICA
Autores
SANTOS, Alcione Miranda dos
SOUZA, Bruno Feres de
CARVALHO, Carolina Abreu de
CAMPOS, Marcos Adriano Garcia
OLIVEIRA, Bruno Luciano Carneiro Alves de
DINIZ, Eduardo Moraes
BRANCO, Maria dos Remedios Freitas Carvalho
QUEIROZ, Rejane Christine de Sousa
CARVALHO, Vitoria Abreu de
Citação
REVISTA DE SAUDE PUBLICA, v.55, article ID 71, 12p, 2021
Resumo
OBJECTIVE: To estimate the 2020 all-cause and COVID-19 excess mortality according to sex, age, race/color, and state, and to compare mortality rates by selected causes with that of the five previous years in Brazil. METHODS: Data from the Mortality Information System were used. Expected deaths for 2020 were estimated from 2015 to 2019 data using a negative binomial log-linear model. RESULTS: Excess deaths in Brazil in 2020 amounted to 13.7%, and the ratio of excess deaths to COVID-19 deaths was 0.90. Reductions in deaths from cardiovascular diseases (CVD), respiratory diseases, and external causes, and an increase in ill-defined causes were all noted. Excess deaths were also found to be heterogeneous, being higher in the Northern, Center-Western, and Northeastern states. In some states, the number of COVID-19 deaths was lower than that of excess deaths, whereas the opposite occurred in others. Moreover, excess deaths were higher in men aged 20 to 59, and in black, yellow, or indigenous individuals. Meanwhile, excess mortality was lower in women, in individuals aged 80 years or older, and in whites. Additionally, deaths among those aged 0 to 19 were 7.2% lower than expected, with reduction in mortality from respiratory diseases and external causes. There was also a drop in mortality due to external causes in men and in those aged 20 to 39 years. Moreover, reductions in deaths from CVD and neoplasms were noted in some states and groups. CONCLUSION: There is evidence of underreporting of COVID-19 deaths and of the possible impact of restrictive measures in the reduction of deaths from external causes and respiratory diseases. The impacts of COVID-19 on mortality were heterogeneous among the states and groups, revealing that regional, demographic, socioeconomic, and racial differences expose individuals in distinct ways to the risk of death from both COVID-19 and other causes.
Palavras-chave
Neoplasms, mortality, Mortality, COVID-19, Cause of Death
Referências
- Adair T, 2020, CRVS BEST PRACTICE A
- Almeida Wanessa da Silva de, 2020, Rev. bras. epidemiol., V23, pe200105, DOI 10.1590/1980-549720200105
- Silva GAE, 2020, CIENC SAUDE COLETIVA, V25, P3345, DOI 10.1590/1413-81232020259.23642020
- Barros AJD, 2020, REV SAUDE PUBL, V54, P29, DOI [10.11606/s1518-8787.2020054002810., 10.11606/s1518-8787.2020054002810]
- Bhopal SS, 2021, LANCET CHILD ADOLESC, V5, pE12, DOI 10.1016/S2352-4642(21)00066-3
- Bienvenu LA, 2020, CARDIOVASC RES, V116, P2197, DOI 10.1093/cvr/cvaa284
- Bocchini B., 2020, QUARENTENA REDUZ 47
- Calderon-Anyosa RJC, 2021, PREV MED, V143, DOI 10.1016/j.ypmed.2020.106331
- Carvalho TA, 2021, DIAGN MICR INFEC DIS, V99, DOI 10.1016/j.diagmicrobio.2020.115258
- de Oliveira RG, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00150120, 10.1590/0102-311x00150120]
- Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331
- França Elisabeth Barboza, 2020, Rev. bras. epidemiol., V23, pe200053, DOI 10.1590/1980-549720200053
- Hills T, 2020, LANCET, V396, P1633, DOI 10.1016/S0140-6736(20)32166-8
- Horta BL, 2020, REV PANAM SALUD PUBL, V44, P1, DOI 10.26633/RPSP.2020.135
- Instituto Brasileiro de Geografia e Estatistica, 2020, PROJ PPPUL TAB PROJ
- Instituto Brasileiro de Geografia e Estatistica, 2021, PESQ NAC AM DOM CONT
- Instituto Brasileiro de Geografia e Estatistica, 2019, SIST EST VIT EST SUB
- Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137
- Jardim B, 2021, COVID 19 BRASIL 2020, DOI [10.1590/SCIELOPREPRINTS.2659, DOI 10.1590/SCIELOPREPRINTS.2659]
- Johns Hopkins University School of Medicine, 2021, MORT AN CAS MORT COU
- Karlinsky Ariel, 2021, medRxiv, DOI 10.1101/2021.01.27.21250604
- Kupek E, 2021, TROP MED INT HEALTH, V26, P1019, DOI 10.1111/tmi.13628
- Leao MLP, 2021, ENVIRON SCI POLLUT R, V28, P41843, DOI 10.1007/s11356-021-13650-x
- Marinho F, 2020, EXCESS MORTALITY BRA
- Meneses-Navarro S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01178-4
- Ministerio da Saude (BR), 2021, PAIN COR OB CONF
- Nandy K, 2020, DIABETES METAB SYND, V14, P1017, DOI 10.1016/j.dsx.2020.06.064
- Prado Marcelo Freitas do, 2020, Rev. bras. ter. intensiva, V32, P224, DOI 10.5935/0103-507x.20200030
- RIBEIRO-JUNIOR MARCELO AUGUSTO FONTENELLE, 2021, Rev. Col. Bras. Cir., V48, pe20202875, DOI 10.1590/0100-6991e-20202875
- Romero DE, 2021, CAD SAUDE PUBLICA, V37, DOI [10.1590/0102-311X00216620, 10.1590/0102-311x00216620]
- Salmon M, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i10
- da Silva LLS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00185020, 10.1590/0102-311x00185020]
- SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848
- Son JY, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.141012
- Szwarcwald CL, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.1590/S1679-49742020000500018, 10.1590/s1679-49742020000500018]
- Werneck GL, 2021, MORTES EVITAVEIS COV
- Orellana JDY, 2021, CAD SAUDE PUBLICA, V37, DOI [10.1590/0102-311X00328720, 10.1590/0102-311x00328720]
- Orellana JDY, 2021, CAD SAUDE PUBLICA, V37, DOI [10.1590/0102-311X00259120, 10.1590/0102-311x00259120]